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Abstract Recent association studies suggest that poly-
morphisms in the promoter and exon 1 upstream region
of the dopamine D4 receptor (DRD4)g e n ep l a ya
functional role in the development of common psychi-
atric illnesses, although there are also conﬂicting results.
In this study, we re-sequenced this region to identify all
genomic variants, and tested them for association with
schizophrenia. A total of 570 Japanese schizophrenic
cases with matched controls were studied by genotyp-
ing all identiﬁed/validated common polymorphisms
(–1106T>C, –906T>C, –809G>A, –616G>C, –521T>C,
–376C>T, –291C>T and 12-bp repeat) and a known
microsatellite (120-bp tandem duplication) in the up-
stream region. A single nucleotide polymorphism (SNP)
–809G>A in the promoter region was found to be sig-
niﬁcantly associated with disease (P=0.018 and 0.032
for allelic and genotypic comparisons, respectively),
although not surviving after Bonferroni correction.
Logisticregressionanalysisshowedthatacombinationof
the four polymorphisms, –809G>A, –616G>C, –291C>T
and the 12-bp repeat, conferred a susceptibility to
schizophrenia. These results suggest that the upstream
variants have a primary functional effect in the etiology
of schizophrenia in the Japanese population.
Keywords Dopamine D4 receptor  Re-sequencing 
Promoter region  Linkage disequilibrium  Haplotype
block  Logistic regression analysis
Introduction
Disturbances in the dopamine neurotransmitter system
have long been suggested to play a crucial role in the
pathogenesis of schizophrenia (Prasad et al. 2002).
However, involvement of dopamine-related genes in
the manifestation of this disorder has been difﬁcult to
determine. The dopamine D4 receptor (DRD4) gene,
located at chromosome 11p15.5 (Gelernter et al. 1992;
Petronis et al. 1993), has received considerable interest
because clozapine, a neuroleptic which is often effec-
tive against treatment-resistant symptoms, has a high
afﬁnity for this receptor (Sanyal and Van Tol 1997;
The nucleotide polymorphism data reported is available in the
DDBJ/EMBL/GenBank databases under the accession number
ss61570833.
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DOI 10.1007/s10038-006-0084-3Van Tol et al. 1991). Also, DRD4 is up-regulated in
postmortem brain tissue from schizophrenic patients
(Murray et al. 1995; Seeman et al. 1993; Stefanis et al.
1998; Sumiyoshi et al. 1995).
To investigate its genetic association with schizo-
phrenia, many groups have examined polymorphisms
of the DRD4 gene. Early studies focused on a 48-bp
variable number of tandem repeat (VNTR) in exon 3.
This tandem repeat comprises 2 (2R) to 11 (11R) 48-bp
repeat units and codes for the third intracellular loop
of the receptor protein (Van Tol et al. 1992). There is
growing genetic evidence linking the VNTR with psy-
chiatric traits or illnesses, such as novelty-seeking
(Benjamin et al. 1996; Ebstein et al. 1996), attention-
deﬁcit hyperactivity disorder (ADHD) (Faraone et al.
2001; LaHoste et al. 1996), and schizophrenia (Hwu
et al. 1998; Jonsson et al. 1996; Kaiser et al. 2000; Sanak
et al. 2005; Serretti et al. 2001), but the results are still
variable.
In recent years, promoter region polymorphisms of
the DRD4 have also received particular attention be-
cause of their possible role in the regulation of gene
transcription. To date, two polymorphisms in the pro-
moter, T allele of the single nucleotide polymorphism
(SNP) –521T>C and a 120-bp tandem duplication
(1.2 kb upstream from the initiation codon), are re-
ported to reduce transcriptional efﬁciency (D’Souza
et al. 2004; Okuyama et al. 1999). Numerous studies
have examined the association of upstream (promoter
region and exon 1) polymorphisms with schizophrenia
and some have shown a positive association (Okuyama
et al. 1999; Xing et al. 2003), although not all were in
full agreement (Hong et al. 1998; Jonsson et al. 2001;
Kohn et al. 1997; Lung et al. 2006; Mitsuyasu et al.
2001; Petronis et al. 1995).
Since previous studies focused primarily on individ-
ual polymorphisms, allelic heterogeneity and/or a rel-
atively weak effect of the variants may partly explain
these inconsistencies. When haplotype construction is
difﬁcult because of a weakness or absence of linkage
disequilibrium (LD) in a genomic interval, as is the case
for the promoter region of DRD4, it may be important
to test for a synergistic interaction between genetic
variants in addition to performing single SNP analysis.
Haplotype analysis is a reasonable strategy, assuming
that the causative allele arises from a speciﬁc ancestral
haplotype. However, this method is inadequate when
there is an accumulation of multiple causative variants
in a restricted genomic stretch. Additionally, haplotypic
analysis is further compromised in regions where LD is
decayed, because of the low statistical power to detect
association due to inﬂated degrees of freedom. There-
fore, clusters of potentially functional variants in
genomic region with tenuous LD are better analyzed
using a logistic regression framework that provides a
powerful test of SNP etiology.
In this study, we examined the 5¢ upstream region of
DRD4, by ﬁrst re-sequencing the region to identify all
genomic variants. We then tested the association of all
identiﬁed/validated common variants individually, as
well as performing synergistic interaction analyses be-
tween them and schizophrenia.
Materials and methods
Subjects
Samples from 570 unrelated cases of schizophrenia
(285 men, 285 women; mean age 47.0±11.4 years), and
570 age and sex matched controls (285 men, 285
women; mean age 46.7±11.1 years) were analyzed. The
diagnosis of schizophrenia was made by consultation
according to DSM-IV criteria with consensus from at
least two experienced psychiatrists. All available
medical records were taken into consideration. Control
subjects were recruited from hospital staff and volun-
teers who showed no evidence of present or past psy-
choses during brief interviews with psychiatrists. All
subjects were from central Japan. The study was
approved by the Ethics Committees of RIKEN,
Hamamatsu University and Chiba University. All
participants provided written informed consent.
Sequence analysis
The upstream region encompassing the promoter re-
gion and exon 1 of the DRD4 gene (from 1,216 bp
upstream of ‘‘A’’ in the start codon to 293 bp down-
stream of this ‘‘A’’) was analyzed by the direct
sequencing of PCR ampliﬁcation from the genomic
DNA of 30 unrelated Japanese schizophrenics. Primer
sequences and detailed information on the reaction
conditions are available upon request. Sequencing was
performed using the DYEnamic ET terminator cycle
sequencing kit (Amersham Biosciences, Piscataway,
N.J., USA) and the ABI PRISM 3730 Genetic Ana-
lyzer (Applied Biosystems, Foster City, Calif., USA).
Polymorphisms were detected by the SEQUENCHER
program (Gene Codes Corporation, Ann Arbor, Mich.,
USA).
Genotyping
SNPs were typed by the TaqMan system (Applied
Biosystems). PCR was performed using an ABI 9700
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123thermocycler and ﬂuorescent signals were analyzed by
an ABI 7900 sequence detector single point measure-
ment and SDS v2.0 software (Applied Biosystems).
Conﬂicts or ﬂagged alleles were resolved by re-geno-
typing. Two microsatellite marker loci, the 120-bp
tandem duplication and the 12-bp repeat polymor-
phism (Fig. 1), were ampliﬁed by PCR using ﬂuores-
cently labeled primers. PCR fragments were analyzed
on an ABI PRISM 3730 Genetic Analyzer (Applied
Biosystems). Genotypes were determined using
GeneScan 3.5.2 and Genotyper 3.6 software (Applied
Biosystems).
Statistical analyses
The allelic and genotypic distributions were tested for
association by Fisher’s exact test for biallelic markers
(SNPs, the 120-bp tandem duplication and the 12-bp
repeat polymorphism).
Haplotypic association analysis was performed using
COCAPHASE in the UNPHASED package (http://
www.rfcgr.mrc.ac.uk/~fdudbrid/software/unphased/)
(Dudbridge 2003). We employed a 2- and 3-marker
sliding window analysis using COCAPHASE. To esti-
mate the degree of LD between pairs of loci, the
standardized disequilibrium coefﬁcient (D¢) was
calculated and haplotype blocks were deﬁned using the
Haploview program (http://www.broad.mit.edu/mpg/
haploview/) (Barrett et al. 2005).
Logistic regression analysis
To test the multiple polymorphisms in the upstream
region for a synergistic effect, stepwise logistic regres-
sion analysis was performed using the SPSS Software
(Release 11.0J) (SPSS Japan, Tokyo, Japan). We
employed a procedure of backward selection in which
we started with all the markers genotyped in the
present study. According to the approach of Cordell
and Clayton (2002), we set dummy variables, x1 and x2,
taking values x1=–1, 0 and 1, x2=–0.5, 0.5 and –0.5, for
genotypes w/w, w/m and m/m, respectively (w: wild-
type, m: mutant).
Results
We re-sequenced the upstream region of the DRD4
gene, and identiﬁed a total of eleven SNPs: –1106T>C,
–930C>G, –906T>C, –873G>A, –809G>A, –616G>C,
–603G>T, –595G>del, –521T>C, –376C>T, and
–291C>T, and a 12-bp repeat polymorphism (Fig. 1).
One novel variant, –930C>G (deposited into GenBank
as ss61570833), was detected in only 1 out of 58 chro-
mosomes. The remaining variants were already present
in the public databases and were validated in Japanese
subjects during the course of this study.
The eight markers, –1106T>C, –906T>C, –809G>A,
–616G>C, –521T>C, –376C>T, –291C>T, and the
12-bp repeat polymorphism in exon 1, were selected
for genotyping using the criterion of a minor allele
frequency >0.05 from our sequencing data. We also
typed the size of the 120-bp tandem duplication
(bi-allelic polymorphism with either one or two repeat
alleles). The information on markers is shown in
Table 1. The 12-bp repeat polymorphism was mostly
bi-allelic with the exception of four chromosomes
(three from schizophrenics and one from controls) that
contained a three-repeat allele.
Allelic and genotypic distributions of the promoter
SNP –809G>A differed signiﬁcantly between cases and
controls (P=0.018 and 0.032 for allelic and genotypic
comparisons, respectively). In the exploratory haplo-
type window analysis, the two-SNP haplotype
5' 5' 3'
12-bp
-809G>A
-616G>C
-376C>T
-521T>C
-906T>C
-1106T>C
120-bp
exon2
113 bp
exon3
659 bp
exon4
203 bp
exon1
285 bp
re-sequenced
region
-603G>T
-873G>A
-930C>G
-595G>del
-291C>T
1 kb
Fig. 1 Genomic structure and location of polymorphic sites
within DRD4. Exons are denoted by boxes, with untranslated
regions in white and translated regions in black. The sizes of
exons and a scale are also shown. SNPs and microsatellites are
indicated by solid squares and triangles, respectively. Re-
sequencing was performed on the upstream region (from
1.2 kb upstream of the initiation codon to the 3¢ end of exon 1)
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123[(–1106C) – (–906C)] tended to be over-represented in
schizophrenia (frequencies in cases and in controls were
0.70 and 0.66, respectively, P=0.0656) (data not shown).
In LD analysis, D¢ values were close to 1 in the
distal [(120-bp repeat) – (–1106T>C) – (–906T>C)]
and proximal [(–376C>T) – (–291C>T) – (–12-bp)]
segments of the upstream region, with each deﬁned as
a haplotype block, but it did not hold for the region in
between (Fig. 2). Decay of LD in this short stretch
(1.2 kb) may imply a high local recombination rate.
Therefore, in addition to conventional haplotype-
window analysis, we employed logistic regression
analysis, which can test a combinatorial effect of mul-
tiple SNPs simultaneously. A combination of four
polymorphisms (–809G>A, –616G>C, –219C>T and
12-bp repeat) appeared to affect susceptibility to
schizophrenia (Table 2).
Discussion
In this study of the DRD4 gene, we focused on the
upstream region, where associations with psychiatric
phenotypes have been previously reported. However,
genetic variants in this region do not show consistent
association with schizophrenia. This may have been
due to insufﬁcient statistical power or inadequate
interrogation of genomic variations in some studies. In
addition, the differences in marker sets between stud-
ies increase the ambiguity when interpreting data. To
minimize these problems, we adopted the thorough
approach of re-sequencing and genotyping all vali-
dated polymorphisms.
Both upstream region variants, the single marker
–809G>A and a multi-marker combination, displayed
association with schizophrenia in this study. The SNP
–521T>C, which was previously reported to show
association with schizophrenia in an independent
Japanese sample set (Okuyama et al. 1999), was not
signiﬁcant in our data set, as in other population data
sets (Ambrosio et al. 2004; Jonsson et al. 2001;
Segman et al. 2003). Since it is conceivable that
particular combinations of multiple variants may
confer an enhanced susceptibility to schizophrenia,
we performed a logistic regression analysis to test all
SNPs in the upstream region for association. This
Table 1 Genotype distributions of bi-allelic polymorphisms from the upstream region of DRD4
Marker dbSNP
ID
Physical
position
Case or
control
n Genotype frequencies P value for
allelic
association
P value for
genotypic
association
–1.2 kb
120-bp repeat
– 625826–626065 1/1 1/2 2/2
Case 569 0.04 0.32 0.64 0.202 0.377
Control 570 0.06 0.34 0.61
–1106 T>C rs936460 626199 T/T T/C C/C
Case 569 0.79 0.20 0.02 0.522 0.644
Control 570 0.76 0.22 0.02
–906 T>C rs3758653 626399 T/T T/C C/C
Case 569 0.66 0.31 0.03 0.116 0.223
Control 569 0.62 0.34 0.05
–809 G>A rs936461 626496 A/A A/G G/G
Case 562 0.03 0.33 0.64 0.018 0.032
Control 564 0.06 0.35 0.59
–616 G>C rs747302 626689 C/C C/G G/G
Case 565 0.09 0.44 0.47 0.769 0.257
Control 568 0.10 0.39 0.50
–521 T>C rs1800955 626784 T/T T/C C/C
Case 566 0.34 0.48 0.19 0.371 0.377
Control 569 0.34 0.50 0.16
–376 C>T rs916455 626929 T/T T/C C/C
Case 561 0.01 0.18 0.81 0.732 0.838
Control 562 0.01 0.19 0.80
–291 C>T rs916457 627014 T/T T/C C/C
Case 565 0.01 0.21 0.79 0.518 0.080
Control 566 0.02 0.19 0.79
Exon 1
12-bp repeat
rs4646983 627392–627391 1/1
a 1/2
a 2/2
a
Case 568 0.02 0.25 0.73 0.512 0.248
Control 569 0.03 0.21 0.76
a Alleles are coded by the number of repeats. Four subjects (three from the schizophrenia and one from the control group) with three
repeats are omitted from this table. Signiﬁcant results are shown in bold type
J Hum Genet (2007) 52:86–91 89
123approach may be more appropriate than conven-
tional haplotype analysis, when examining the up-
stream region of the DRD4 gene where there is
evidence of LD decay in a relatively short genomic
stretch and most markers do not correlate with each
other. Results appear to indicate a synergistic inter-
action among the four promoter polymorphisms in
the DRD4 gene. These results should be treated with
caution since there are limitations to the present
association study. Firstly, this is a case-control study,
where false positive ﬁndings due to population
stratiﬁcation can occur. Analysis of this sample set
using STRUCTURE software (Pritchard et al. 2000)
detected no evidence of population stratiﬁcation
(Shimizu et al. 2006). To address this issue further,
we also performed a transmission disequilibrium test.
This testing failed to replicate the association of
–809G>A in a sample set of 80 complete schizo-
phrenic trios (data not shown). This sample size
would have only a limited statistical power to detect
true association. Secondly, the signiﬁcance of the
–809G>A polymorphism in the promoter region
disappeared after Bonferroni correction for multiple
testing. Thirdly, the sample size is obviously limited
and so the insigniﬁcant result for –521T>C needs to
be interpreted cautiously. The sample size in this
study had a power of 0.59 to detect a susceptibility
variant with a relatively small effect (relative risk =
1.2 and 1.44 for heterozygotes and homozygotes,
respectively), when the allele frequency is 0.41. This
frequency equals that of SNP –521C, whose associa-
tion with schizophrenia has been previously reported
(Purcell et al. 2003; Xing et al. 2003).
In conclusion, to our knowledge, this is the ﬁrst
study that highlights a possible combinatorial effect of
promoter SNPs in the DRD4 gene. It will be interest-
ing to determine whether this multi-marker association
can be conﬁrmed in independent data sets, where
samples are well-deﬁned in terms of clinical variables
such as symptoms, age-at-onset, severity, medication
type, and response to antipsychotic treatment. Fur-
thermore, it will be important to examine the func-
tional effects of variant combinations, to understand
the mechanisms by which they increase or decrease
susceptibility to schizophrenia.
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